MASSDEVICE ON CALL —Illumina’s (NSDQ:ILMN) board of directors adopted a "poison pill" strategy in response to a hostile takeover bid by Roche (PINK:RHHBY).

Illumina adopted a rights agreement which allows shareholders other than the a bidder to buy additional shares at a discounted price, potentially deterring would-be bidders by increasing costs.